Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to UAU201213126UpriorityCriticalpatent/UA76361U/en
Publication of UA76361UpublicationCriticalpatent/UA76361U/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Спосіб корекції експериментальної діабетичної ретинопатії за допомогою медикаментозних препаратів. Застосовують комбінацію таурину у дозі 300 мг/кг маси тіла та вітаміну С у дозі 200 мг/кг маси тіла щоденно перорально протягом 6 тижнів.Method for correction of experimental diabetic retinopathy with medication. A combination of taurine at a dose of 300 mg / kg body weight and vitamin C at a dose of 200 mg / kg body weight is administered orally daily for 6 weeks.
UAU201213126U2012-11-192012-11-19
METHOD FOR CORRECTION OF EXPERIMENTAL DIABETIC RETINOPATHY
UA76361U
(en)
Method to treat a human patient with multiple sclerosis with laquinimod, at a daily dose of about 1.2mg; an oral unit dosage form of 1.2 mg of laquinimod and a carrier